HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $626,343 | +17.3% | 6,992 | +11.5% | 0.02% | +15.0% |
Q2 2023 | $533,743 | +16.1% | 6,269 | +12.9% | 0.02% | +5.3% |
Q1 2023 | $459,676 | -56.3% | 5,555 | -58.5% | 0.02% | -69.8% |
Q4 2022 | $1,052,652 | -52.2% | 13,384 | -67.8% | 0.06% | -36.4% |
Q4 2021 | $2,202,000 | +19.2% | 41,522 | +49.9% | 0.10% | -16.8% |
Q2 2021 | $1,847,000 | +15.9% | 27,709 | +93.0% | 0.12% | +50.6% |
Q1 2021 | $1,594,000 | +347.8% | 14,359 | +379.4% | 0.08% | +426.7% |
Q4 2020 | $356,000 | -40.8% | 2,995 | -56.5% | 0.02% | -46.4% |
Q3 2020 | $601,000 | -68.7% | 6,891 | -67.9% | 0.03% | -71.4% |
Q2 2020 | $1,920,000 | +190.9% | 21,442 | +223.9% | 0.10% | +104.2% |
Q1 2020 | $660,000 | -79.4% | 6,619 | -76.3% | 0.05% | -66.0% |
Q4 2019 | $3,204,000 | +856.4% | 27,884 | +951.4% | 0.14% | +729.4% |
Q3 2019 | $335,000 | -20.2% | 2,652 | -44.8% | 0.02% | -32.0% |
Q1 2019 | $420,000 | -66.4% | 4,800 | -77.7% | 0.02% | -70.9% |
Q4 2017 | $1,250,000 | +105.9% | 21,528 | +46.6% | 0.09% | +45.8% |
Q2 2015 | $607,000 | – | 14,683 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |